Navigation Links
Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
Date:7/17/2013

RICHMOND, Calif., July 17, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of groundbreaking research using zinc finger DNA-binding protein (ZFP) technology to insert a gene that permanently "silences" the extra copy of chromosome 21, which is the root cause of Down syndrome (DS). This advance, accomplished in induced pluripotent stem cells (iPSCs) derived from DS patients, provides a model to study the basic biology of DS which may enable the development of drugs that can potentially rebalance the cellular processes and pathologies that are impacted by this disorder. 

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

The work was led by the laboratory of Jeanne Lawrence, Ph.D., interim chair and professor of cell & developmental biology at the University of Massachusetts Medical School, in collaboration with Sangamo scientists and was published as an Advance Online Publication in Nature http://dx.doi.org/10.1038/nature12394.

"Until now our ability to correct cells carrying a chromosomal abnormality, by specifically silencing, or shutting down, expression of essentially all genes across a chromosome of our choosing was outside the realm of possibility," said Dr. Lawrence. "However, this goal has been realized by using ZFNs to introduce, into a defined site in chromosome 21, a copy of a gene that normally functions to shut down the extra copy of the X chromosome in females. This provides a means to understand the cellular pathologies of DS, important for development of therapeutics, and also provides a needed model to study human chromosome inactivation."

Down syndrome, or Trisomy 21, is a gen
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
2. Sangamo BioSciences Reports First Quarter 2013 Financial Results
3. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
4. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
5. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
6. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
7. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
8. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
9. 3-V Biosciences Completes $20 Million Series C Financing
10. New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research
11. Alzheimers Drug Discovery Foundation Supports Madera Biosciences to Advance Small Molecule Drugs that Upregulate apoE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Integrated Silicon Solution, Inc. ... memory and analog IC solutions, today announced that it ... 24, 2014, at 7:00 a.m. Pacific Time (10:00 a.m. ... the fiscal 2014 third quarter ended June 30, 2014. ... dial 1-888-556-4997 before 6:50 a.m. Pacific time on July ...
(Date:7/10/2014)... , July 10, 2014  BC Technical, the ... MiE America , Inc., a leading provider of ... into a long-term agreement naming BC Technical as the ... MiE and BC Technical announced today ... to establish BC Technical as the service and systems ...
(Date:7/10/2014)... 2014  Decision Resources Group finds that while ... specialists are willing to prescribe Durata,s Dalvance (dalbavancin) ... as OPAT, approximately two-thirds of the respondents reported ... hospital inpatients. However, our findings indicate that nearly ... on OPAT following hospital discharge, and most are ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... Inc. today announced the completion of subject dosing ... and bioavailability after administration of two proprietary formulations ... collaboration with the University of Minnesota and James ... experts in clinical research of the nasal delivery ...
... MYL ) today announced that its subsidiary Mylan Pharmaceuticals ... 500 mg, the generic version of Novartis, Famvir® Tablets, a ... sales of approximately $196 million for the 12 months ending ... Currently, Mylan has 165 ANDAs pending FDA approval representing $98.5 ...
Cached Medicine Technology:Neurelis Announces Completion of Dosing in Study of Intranasal Diazepam 2
(Date:7/10/2014)... News) -- Teens who are sensitive to light or ... emotional symptoms such as anxiety and depression, a new ... may exacerbate issues teens experience after concussion may help ... decisions about when to return to play and what ... authors Lisa Koehl and Dong Han, of the University ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, 2014 (HealthDay ... regularly between outspoken celebrities or loudmouth pundits -- too much ... study suggests. High amounts of Twitter use can lead ... in a long-term relationship, according to findings from an online ... can lead to cheating and breakups, the researchers concluded, although ...
(Date:7/10/2014)... responders felt better prepared to respond to an active ... a new study in the journal Prehospital and ... specifically examine the EMS provider comfort level with respect ... yet been neutralized or working with law enforcement personnel ... High School shooting, the Virginia Tech campus shooting, the ...
(Date:7/10/2014)... PHILADELPHIA Reducing the amount of alcoholic beverages ... health, including a reduced risk of coronary heart ... pressure, according to a new multi-center study published ... the Perelman School of Medicine at the University ... previous studies which suggest that consuming light-to-moderate amounts ...
(Date:7/10/2014)... Department of Health and Human Services (HHS) has announced ... Center Seidman Cancer Center totaling $4.7 million to support ... patients with complex cancer. , Titled "Evidence-Conformant Oncology ... at UH to enhance care for adult cancer patients ... high health care utilization. , "We believe ...
Breaking Medicine News(10 mins):Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Active shooter training increases comfort level of emergency responders 2Health News:New study shows drinking alcohol provides no heart health benefit 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3
... 17 (HealthDay News) -- Children with bipolar disorder and ... time looking at the eyes when trying to identify ... researchers say. This new study finding may help ... dysregulation have difficulty determining other people,s emotional expressions, said ...
... 17, 2011 -- Factors such as low hemoglobin levels, increased ... higher risk of silent cerebral infarcts (SCIs), or silent strokes, ... from a large, first-of-its-kind study published online today ... the American Society of Hematology (ASH). Silent strokes ...
... (HealthDay News) -- Most people who join gangs have ... that challenges previous research suggesting gang membership is driven ... an antisocial personality are impulsive, lack self-discipline and self-control, ... this, they may be excluded from groups at school ...
... increasingly common, and a dangerous lack of new infection ... than ever to use existing antibiotics appropriately. This week, ... care providers, and policymakers about when antibiotics can help, ... harm than good, and the tremendous need for new ...
... that keep blood vessels open to treat heart disease ... in the Journal of Interventional Cardiology . A ... Grines, of the Detroit Medical Center Cardiovascular Institute, and ... attack after the recently marketed Ion stent (Boston Scientific, ...
... InDevR, a Boulder-based biotechnology company that develops advanced ... viruses and other microorganisms, announced today the launch ... colorimetric detection system that incorporates core technology licensed ... will enhance laboratories around the world by offering ...
Cached Medicine News:Health News:Bipolar Kids May Focus on Different Facial Features 2Health News:Study identifies 'silent' stroke risk factors for children with sickle cell anemia 2Health News:Preserving lifesaving antibiotics today and for the future 2Health News:Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU 2
ThermalSeal RT (5mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates. Will not wrinkle in the freezer....
DMSO-resistant microplate sealing film...
Sealing tape featuring 3M adhesive technology. Opaque and strong. Prevents photo-degradation....
Aluminum Seal, Reflective, Bulk...
Medicine Products: